Pioneering organ level drug discovery
Organome Technology
Target based drug discovery: finding a small set of molecular targets and designing compounds that modulates those specific targets Current prevailing paradigm: What we are missing:
Human biology is a complex system, but current available technologies are not able to captures the dynamic changes caused by disease and treatment at higher levels. Drug development needs to look beyond target based drug discovery to design better drugs
By going beyond target based approach, AIVIVO pioneers a new drug discovery paradigm with the Organome Platform, capturing the dynamic effect of diseases and treatments at organ and organ systems level for the first time, enabling the discovery of novel treatments with higher clinical predictability Learn More
